BIO Overview
BIO is a decentralized science (Desci) protocol designed to advance biotech research through community-owned DAOs, tokenized scientific IP, and open financing channels. It provides a financial layer to support early science by supporting the creation and management of biotech DAOs, where stakeholders can fund, develop, and trade IP assets. BI0's mission is to accelerate scientific innovation using blockchain technology, making it easily accessible and collaborative.
DeSci 2.0: How BIO will revolutionize biotechnology
BIO is an autonomous, community-owned launchpad for the scientific community - like pump.fun or daos.fun are to memecoins, BIO will make curating, forming, and funding the scientific community fun, accessible, and open.
BIO Tokenomics (Bionomics) recently upgraded to allocate 55% more funding to the community, fulfilling our promise to be a community owned launchpad. In the first year, BIO is 100% community owned, and all team and internal staff will be vested in 6 years. Great science needs to be achieved. Do it slowly, then all at once.
The BIO roadmap for the coming months includes mainnet launch and productizing permissionless creation of AI-driven DeSci DAOs designed to cure any disease and the wildest scientific frontiers. We are here to accelerate the development of all life forms.
DeSci is at a crossroads: new launchpad mechanisms, memecoins, and communities are spreading like wildfire — yet public infrastructure to launch, manage, and accelerate DeSci DAOs is severely lacking. DeSci needs liquidity, a standardized framework to build trust, and a strong crypto railroad to bring scientists and patients into DeFi.
What if we could inject memecoin liquidity into funding science? The public would look at cryptocurrencies in a completely different light.
BIO's mission is to be a permissionless launchpad and accelerator network that makes creating a DeSci DAO as easy as starting a Subreddit. BioDAO is a Reddit community with a bank account that can build a real-world IP portfolio like a pharmaceutical company. pump.fun or DAOS.FUN is for on-chain scientific communities where patients, scientists, and investors can seed, expand, and co-own new drugs and therapies outside of traditional pharmaceuticals. And commercialize them.
In recent years, we have learned a lot about bringing science on-chain, incubating over $70 million worth of projects in the leading DeSci DAO, and funding tens of millions of dollars in research. From VitaDAO’s longevity projects VitaRNA and VitaFAST, to ValleyDAO’s HempKnit, to HairDAO’s hair loss solutions.
Following the first wave of DeSci DAOs, we are starting to incubate the next wave, inviting biotech builders and scientists to apply for acceleration and support from the BIO Protocol. The fruits of the protocol’s labor are a network of BioDAOs, curated by BIO token holders who direct resources to the most promising on-chain science, entering a leaderboard driven by tokenization and bonding curve design mechanisms. The best DAOs should rise quickly and achieve full autonomy.
In recent months, we have received a large number of applications from outstanding founders. The applicants for the second batch of early admissions include:
Long COVID Labs: Accelerating the search for cures for more than 100 million patients worldwide, led by former Stanford neuroscientist Rohan Dixit, who self-treated his own Long COVID.
Curetopia: Targeting the $1 trillion rare disease sector, led by Y-Combinator alum, Harvard PhD, and rare disease entrepreneur Ethan Perlstein, who advanced a drug into Phase 3 clinical trials for just $5 million (a fraction of the typical $100 million+ cost).
Quantum Biology DAO: Building a quantum microscope to observe quantum biological phenomena, led by one of the world’s leading quantum biology scientists, Dr. Clarice Aiello, PhD, MIT.
Upgrading bioeconomics
As more funding, users, and scientists enter the field, the vision and structure of the BIO protocol becomes clearer. Given the importance of active community participation, we propose an upgrade to Bionomics that allocates a larger share of BIO tokens to community and ecosystem participants. We have allocated more than 13% of the token supply to the community. In the first year, almost 100% of the tokens belong to the community.
Notably, a large portion of the tokens allocated to the core team have been reallocated to community control, while a portion of @Molecule_dao's allocation (5% of the BIO supply) has been allocated to the Ecosystem Fund. One of the core missions of this fund is to support the development of decentralized AI technologies to accelerate network R&D. We envision the AI Research Agent to be deeply integrated with BioDAO internally and externally, coordinating 24/7 research efforts across the network.
Biological Roadmap
To achieve our goal of accelerating decentralized science, we have developed a roadmap covering key milestones over the next 6 months. These milestones may change as the market evolves and community feedback shapes our trajectory, but these are our current North Stars.
LF-Acceleration
The Genesis phase of BIO has been completed, raising over $35 million for on-chain science. These tokens make up the BIO Treasury, a diversified portfolio of BioDAO assets and tokenized IP that will accrue stakes in future BioDAOs as they are voted into the network.
It's time to speed up biology!
BIO has been very popular recently. All major platforms and communities are pushing it and looking forward to its performance after it goes online. In 2025, this big bull will witness the power of BIO, and it will start to grow a hundredfold! !